i
Loading Page
loading, please wait

Select Year:

Home > OR Providers
placeholder image of provider

Dr. Christopher Andrew Yasenchak, MD

(No ratings)

Specializes in: Adult Oncology and Adult Hematology
Penn State College of Medicine (1999)
444 Nw Elks Drive
Corvallis, OR 97330

Dr. Christopher Andrew Yasenchak, MD is an oncologist in Newport, OR specializing in adult oncology and adult hematology. He graduated from Penn State College of Medicine in 1999 and has 26 years of experience. Dr. Christopher Andrew Yasenchak, MD is affiliated with Samaritan Health System and ONCOLOGY ASSOCIATES OF OREGON P C.

View Doctor's Full Profile (541) 754-1256

Office Locations

2039 N Coast Highway
Newport, OR 97365
open_in_new
2615 Willetta Street Sw Building C
Albany, OR 97321
open_in_new
3355 Riverbend Drive Suite 240
Springfield, OR 97477
open_in_new

Samaritan Health System

340 9th Street
Florence, OR 97439
(541) 683-5001
(541) 683-1422
open_in_new

Samaritan Health System

444 Nw Elks Drive
Corvallis, OR 97330
(541) 754-1256
open_in_new
520 Country Club Road
Eugene, OR 97401
open_in_new

Noteworthy Medicare Patient Procedures Performed by Dr. Christopher Andrew Yasenchak, MD in 2023

Click on any procedure below to see further details on volume and pricing among Medicare patients.

Top 5%

By Affordability:

hepatitis B antibody testing
hepatitis B core antibody testing
hepatitis B surface antibody testing
hepatitis C antibody screening
hepatitis C screening
hepatitis C testing
total hepatitis B core antibody testing

In 2023, Dr. Christopher Andrew Yasenchak, MD had a list price for hepatitis B antibody testing, hepatitis B core antibody testing, hepatitis B surface antibody testing, hepatitis C antibody screening, hepatitis C screening, hepatitis C testing, and total hepatitis B core antibody testing that was lower than the list prices billed to Medicare by 95% of providers in related specialties within Oregon. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

Top 25%

By Volume:

blood draw
IgM test
lab tests
lactate dehydrogenase test
phlebotomy for lab tests
thyroid blood test

By Affordability:

blood count tests
complete blood count

In 2013, among providers in related specialties within Oregon, Dr. Christopher Andrew Yasenchak, MD performed more blood draw, IgM test, lab tests, lactate dehydrogenase (LDH) test, phlebotomy for lab tests, and thyroid blood test procedures for Medicare patients than 75% of them and he also had a list price for blood count tests, and complete blood count (CBC) that was lower than the list prices billed to Medicare by 75% of them. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

The top procedures that Dr. Christopher Andrew Yasenchak, MD treated as an oncologist in Newport, OR during 2013 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Christopher Andrew Yasenchak, MD for Medicare patients.

aspiration 16
biological response modifier (BRM) therapy 142
blood draw 456
bone marrow tests 32
chemotherapy 142
diagnostic procedures 32
doctor visit 627
hormone therapy 13
hospital care 54
inpatient care 54
lab tests 1325
minimally invasive procedures 198
port flush 25

2013 Medicare Patient Data

Information about Medicare patients treated by Dr. Christopher Andrew Yasenchak, MD.

Gender
Male 121
Female 144
Age
From 65 to 74 109
From 75 to 84 85
85 and over 44
Less than 65 27

Conditions of Medicare patients treated by Dr. Christopher Andrew Yasenchak, MD in 2013

The most common conditions of Medicare patients that Dr. Christopher Andrew Yasenchak, MD treated during 2013 were hypertension, high cholesterol, cancer and chronic kidney disease.

Hypertension 53
High Cholesterol 39
Stroke 0
Ischemic Heart Disease 26
Depression 16
Chronic Kidney Disease 26
Asthma 6
Osteoperosis 8
Atrial Fibrilation 11
Heart Failure 15
Chronic Obstructive Pulmonary Disease 9
Diabetes 18
Dementia 6
Cancer 37

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

The top procedures that Dr. Christopher Andrew Yasenchak, MD treated as an oncologist in Newport, OR during 2014 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Christopher Andrew Yasenchak, MD for Medicare patients.

aspiration 16
biological response modifier (BRM) therapy 157
blood draw 474
bone marrow tests 33
chemotherapy 157
diagnostic procedures 33
doctor visit 494
hospital care 33
inpatient care 33
lab tests 1383
minimally invasive procedures 220

2014 Medicare Patient Data

Information about Medicare patients treated by Dr. Christopher Andrew Yasenchak, MD.

Gender
Male 153
Female 172
Ethnicity
Non-Hispanic White 311
Black 0
Hispanic 0
Asian 0
Other 0
Native American 0
Age
From 65 to 74 143
From 75 to 84 98
85 and over 38
Less than 65 46

Conditions of Medicare patients treated by Dr. Christopher Andrew Yasenchak, MD in 2014

The most common conditions of Medicare patients that Dr. Christopher Andrew Yasenchak, MD treated during 2014 were hypertension, high cholesterol, cancer and chronic kidney disease.

Hypertension 52
High Cholesterol 37
Stroke 4
Ischemic Heart Disease 26
Depression 15
Chronic Kidney Disease 30
Asthma 3
Osteoperosis 4
Atrial Fibrilation 12
Heart Failure 17
Chronic Obstructive Pulmonary Disease 8
Diabetes 19
Dementia 4
Cancer 36

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

The top procedures that Dr. Christopher Andrew Yasenchak, MD treated as an oncologist in Newport, OR during 2015 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Christopher Andrew Yasenchak, MD for Medicare patients.

abdominal imaging 16
aspiration 19
biological response modifier (BRM) therapy 265
blood draw 866
bone marrow tests 39
chemotherapy 265
CT scan 32
diagnostic procedures 39
doctor visit 989
hospital care 33
inpatient care 33
lab tests 2828
minimally invasive procedures 366
pelvic imaging 16
thoracic (chest) imaging 16

2015 Medicare Patient Data

Information about Medicare patients treated by Dr. Christopher Andrew Yasenchak, MD.

Gender
Male 314
Female 372
Ethnicity
Non-Hispanic White 650
Black 0
Hispanic 0
Asian 0
Other 0
Native American 0
Age
From 65 to 74 320
From 75 to 84 196
85 and over 62
Less than 65 108

Conditions of Medicare patients treated by Dr. Christopher Andrew Yasenchak, MD in 2015

The most common conditions of Medicare patients that Dr. Christopher Andrew Yasenchak, MD treated during 2015 were hypertension, high cholesterol, chronic kidney disease and cancer.

Hypertension 50
High Cholesterol 33
Stroke 5
Ischemic Heart Disease 22
Depression 19
Chronic Kidney Disease 31
Asthma 9
Osteoperosis 10
Atrial Fibrilation 12
Heart Failure 19
Chronic Obstructive Pulmonary Disease 11
Diabetes 23
Dementia 5
Cancer 28

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

The top procedures that Dr. Christopher Andrew Yasenchak, MD treated as an oncologist in Newport, OR during 2016 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Christopher Andrew Yasenchak, MD for Medicare patients.

abdominal imaging 34
aspiration 15
biological response modifier (BRM) therapy 383
blood draw 1141
bone marrow tests 30
chemotherapy 383
CT scan 85
diagnostic procedures 30
doctor visit 1197
hospital care 67
inpatient care 67
lab tests 3561
minimally invasive procedures 495
pelvic imaging 34
port flush 20
thoracic (chest) imaging 51

2016 Medicare Patient Data

Information about Medicare patients treated by Dr. Christopher Andrew Yasenchak, MD.

Gender
Male 199
Female 213
Ethnicity
Non-Hispanic White 385
Black 0
Hispanic 0
Asian 0
Other 0
Native American 0
Age
From 65 to 74 217
From 75 to 84 107
85 and over 38
Less than 65 50

Conditions of Medicare patients treated by Dr. Christopher Andrew Yasenchak, MD in 2016

The most common conditions of Medicare patients that Dr. Christopher Andrew Yasenchak, MD treated during 2016 were hypertension, high cholesterol, chronic kidney disease and cancer.

Hypertension 53
High Cholesterol 36
Stroke 0
Ischemic Heart Disease 25
Depression 16
Chronic Kidney Disease 33
Asthma 17
Osteoperosis 7
Atrial Fibrilation 8
Heart Failure 17
Chronic Obstructive Pulmonary Disease 14
Diabetes 22
Dementia 6
Cancer 31

Medicare Procedure and Patient Information

2017 Medicare Procedure Volume

The top procedures that Dr. Christopher Andrew Yasenchak, MD treated as an oncologist in Newport, OR during 2017 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Christopher Andrew Yasenchak, MD for Medicare patients.

abdominal imaging 34
biological response modifier (BRM) therapy 330
blood draw 1001
chemotherapy 330
CT scan 81
doctor visit 1108
hospital care 45
inpatient care 45
lab tests 2655
minimally invasive procedures 427
pelvic imaging 34
port flush 22
thoracic (chest) imaging 47
thyroid function tests 49

2017 Medicare Patient Data

Information about Medicare patients treated by Dr. Christopher Andrew Yasenchak, MD.

Gender
Male 213
Female 244
Ethnicity
Non-Hispanic White 427
Black 0
Hispanic 0
Asian 0
Other 12
Native American 0
Age
From 65 to 74 230
From 75 to 84 136
85 and over 42
Less than 65 49

Conditions of Medicare patients treated by Dr. Christopher Andrew Yasenchak, MD in 2017

The most common conditions of Medicare patients that Dr. Christopher Andrew Yasenchak, MD treated during 2017 were hypertension, cancer, chronic kidney disease and high cholesterol.

Hypertension 51
High Cholesterol 33
Stroke 4
Ischemic Heart Disease 25
Depression 18
Chronic Kidney Disease 35
Asthma 6
Osteoperosis 7
Atrial Fibrilation 9
Heart Failure 17
Chronic Obstructive Pulmonary Disease 14
Diabetes 23
Dementia 5
Cancer 35

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

The top procedures that Dr. Christopher Andrew Yasenchak, MD treated as an oncologist in Newport, OR during 2018 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Christopher Andrew Yasenchak, MD for Medicare patients.

abdominal imaging 27
biological response modifier (BRM) therapy 215
blood draw 767
chemotherapy 215
CT scan 53
doctor visit 743
hospital care 44
inpatient care 44
lab tests 1977
minimally invasive procedures 268
pelvic imaging 27
port flush 18
thoracic (chest) imaging 26
thyroid function tests 69

2018 Medicare Patient Data

Information about Medicare patients treated by Dr. Christopher Andrew Yasenchak, MD.

Gender
Male 211
Female 227
Ethnicity
Non-Hispanic White 408
Black 0
Hispanic 11
Asian 0
Other 0
Native American 0
Age
From 65 to 74 221
From 75 to 84 132
85 and over 31
Less than 65 54

Conditions of Medicare patients treated by Dr. Christopher Andrew Yasenchak, MD in 2018

The most common conditions of Medicare patients that Dr. Christopher Andrew Yasenchak, MD treated during 2018 were hypertension, high cholesterol, cancer and chronic kidney disease.

Hypertension 53
High Cholesterol 39
Stroke 0
Ischemic Heart Disease 21
Depression 19
Chronic Kidney Disease 36
Asthma 7
Osteoperosis 6
Atrial Fibrilation 8
Heart Failure 16
Chronic Obstructive Pulmonary Disease 15
Diabetes 23
Dementia 5
Cancer 37

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

The top procedures that Dr. Christopher Andrew Yasenchak, MD treated as an oncologist in Newport, OR during 2019 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Christopher Andrew Yasenchak, MD for Medicare patients.

abdominal imaging 26
biological response modifier (BRM) therapy 276
blood draw 927
chemotherapy 276
CT scan 58
doctor visit 809
hospital care 43
inpatient care 43
lab tests 2373
minimally invasive procedures 372
pelvic imaging 26
port flush 33
thoracic (chest) imaging 32
thyroid function tests 70

2019 Medicare Patient Data

Information about Medicare patients treated by Dr. Christopher Andrew Yasenchak, MD.

Gender
Male 206
Female 263
Ethnicity
Non-Hispanic White 442
Black 0
Hispanic 0
Asian 0
Other 0
Native American 0
Age
From 65 to 74 256
From 75 to 84 140
85 and over 30
Less than 65 43

Conditions of Medicare patients treated by Dr. Christopher Andrew Yasenchak, MD in 2019

The most common conditions of Medicare patients that Dr. Christopher Andrew Yasenchak, MD treated during 2019 were hypertension, high cholesterol, chronic kidney disease and cancer.

Hypertension 55
High Cholesterol 42
Stroke 4
Ischemic Heart Disease 26
Depression 23
Chronic Kidney Disease 38
Asthma 8
Osteoperosis 9
Atrial Fibrilation 12
Heart Failure 18
Chronic Obstructive Pulmonary Disease 16
Diabetes 23
Dementia 9
Cancer 34

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

The top procedures that Dr. Christopher Andrew Yasenchak, MD treated as an oncologist in Newport, OR during 2020 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Christopher Andrew Yasenchak, MD for Medicare patients.

abdominal imaging 14
biological response modifier (BRM) therapy 220
blood draw 865
chemotherapy 220
CT scan 34
doctor visit 704
hormone therapy 40
hospital care 19
inpatient care 19
lab tests 2229
minimally invasive procedures 300
pelvic imaging 14
port flush 20
thoracic (chest) imaging 20
thyroid function tests 96

2020 Medicare Patient Data

Information about Medicare patients treated by Dr. Christopher Andrew Yasenchak, MD.

Gender
Male 227
Female 238
Ethnicity
Non-Hispanic White 441
Black 0
Hispanic 0
Asian 0
Other 0
Native American 0
Age
From 65 to 74 243
From 75 to 84 146
85 and over 31
Less than 65 45

Conditions of Medicare patients treated by Dr. Christopher Andrew Yasenchak, MD in 2020

The most common conditions of Medicare patients that Dr. Christopher Andrew Yasenchak, MD treated during 2020 were hypertension, cancer, high cholesterol and chronic kidney disease.

Hypertension 52
High Cholesterol 38
Stroke 0
Ischemic Heart Disease 26
Depression 22
Chronic Kidney Disease 36
Asthma 7
Osteoperosis 9
Atrial Fibrilation 10
Heart Failure 19
Chronic Obstructive Pulmonary Disease 13
Diabetes 22
Dementia 6
Cancer 39

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

The top procedures that Dr. Christopher Andrew Yasenchak, MD treated as an oncologist in Newport, OR during 2021 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Christopher Andrew Yasenchak, MD for Medicare patients.

abdominal imaging 34
biological response modifier (BRM) therapy 215
blood draw 856
chemotherapy 215
CT scan 72
doctor visit 763
hormone therapy 43
hospital care 36
inpatient care 36
lab tests 2563
minimally invasive procedures 277
pelvic imaging 34
thoracic (chest) imaging 38
thyroid function tests 162

2021 Medicare Patient Data

Information about Medicare patients treated by Dr. Christopher Andrew Yasenchak, MD.

Gender
Male 223
Female 237
Ethnicity
Non-Hispanic White 438
Black 0
Hispanic 0
Asian 0
Other 0
Native American 0
Age
From 65 to 74 241
From 75 to 84 148
85 and over 34
Less than 65 37

Conditions of Medicare patients treated by Dr. Christopher Andrew Yasenchak, MD in 2021

The most common conditions of Medicare patients that Dr. Christopher Andrew Yasenchak, MD treated during 2021 were hypertension, high cholesterol, chronic kidney disease and cancer.

Hypertension 55
High Cholesterol 45
Stroke 4
Ischemic Heart Disease 26
Depression 25
Chronic Kidney Disease 43
Asthma 7
Osteoperosis 9
Atrial Fibrilation 10
Heart Failure 18
Chronic Obstructive Pulmonary Disease 16
Diabetes 25
Dementia 8
Cancer 40

Medicare Procedure and Patient Information

2022 Medicare Procedure Volume

The top procedures that Dr. Christopher Andrew Yasenchak, MD treated as an oncologist in Newport, OR during 2022 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Christopher Andrew Yasenchak, MD for Medicare patients.

abdominal imaging 21
biological response modifier (BRM) therapy 214
blood draw 876
chemotherapy 214
CT scan 41
doctor visit 812
hospital care 37
inpatient care 37
lab tests 2604
minimally invasive procedures 287
pelvic imaging 21
thoracic (chest) imaging 20
thyroid function tests 192

2022 Medicare Patient Data

Information about Medicare patients treated by Dr. Christopher Andrew Yasenchak, MD.

Gender
Male 206
Female 214
Ethnicity
Non-Hispanic White 393
Black 0
Hispanic 0
Asian 0
Other 12
Native American 0
Age
From 65 to 74 211
From 75 to 84 145
85 and over 30
Less than 65 34

Conditions of Medicare patients treated by Dr. Christopher Andrew Yasenchak, MD in 2022

The most common conditions of Medicare patients that Dr. Christopher Andrew Yasenchak, MD treated during 2022 were hypertension, high cholesterol, cancer and chronic kidney disease.

Hypertension 66
High Cholesterol 62
Stroke 5
Ischemic Heart Disease 20
Depression 20
Chronic Kidney Disease 29
Asthma 9
Osteoperosis 16
Atrial Fibrilation 18
Heart Failure 20
Chronic Obstructive Pulmonary Disease 19
Diabetes 25
Dementia 4
Cancer 41

Medicare Procedure and Patient Information

2023 Medicare Procedure Volume

The top procedures that Dr. Christopher Andrew Yasenchak, MD treated as an oncologist in Newport, OR during 2023 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Christopher Andrew Yasenchak, MD for Medicare patients.

biological response modifier (BRM) therapy 172
blood draw 810
chemotherapy 172
doctor visit 706
hormone therapy 36
hospital care 38
inpatient care 38
lab tests 2432
minimally invasive procedures 236
preventive care 13
thyroid function tests 96

2023 Medicare Patient Data

Information about Medicare patients treated by Dr. Christopher Andrew Yasenchak, MD.

Gender
Male 195
Female 239
Ethnicity
Non-Hispanic White 411
Black 0
Hispanic 0
Asian 0
Other 0
Native American 0
Age
From 65 to 74 209
From 75 to 84 157
85 and over 35
Less than 65 33

Conditions of Medicare patients treated by Dr. Christopher Andrew Yasenchak, MD in 2023

The most common conditions of Medicare patients that Dr. Christopher Andrew Yasenchak, MD treated during 2023 were hypertension, high cholesterol, cancer and chronic kidney disease.

Hypertension 67
High Cholesterol 61
Stroke 9
Ischemic Heart Disease 22
Depression 24
Chronic Kidney Disease 30
Asthma 10
Osteoperosis 15
Atrial Fibrilation 21
Heart Failure 21
Chronic Obstructive Pulmonary Disease 19
Diabetes 22
Dementia 5
Cancer 39

Medicare Procedure and Patient Information

Average Medicare Procedure Volume From 2013 - 2023

Volume of procedures performed by Dr. Christopher Andrew Yasenchak, MD for Medicare patients.

The highest averages for the top procedures that Dr. Christopher Andrew Yasenchak, MD treated as an oncologist in Newport, OR were lab tests, blood draw, minimally invasive procedures and chemotherapy.

abdominal imaging 25
aspiration 16
biological response modifier (BRM) therapy 235
blood draw 821
bone marrow tests 33
chemotherapy 235
CT scan 57
diagnostic procedures 33
doctor visit 813
hormone therapy 33
hospital care 40
inpatient care 40
lab tests 2357
minimally invasive procedures 313
pelvic imaging 25
preventive care 13
thoracic (chest) imaging 31
thyroid function tests 104

Average Medicare Patient Data From 2013 - 2023

Information about Medicare patients treated by Dr. Christopher Andrew Yasenchak, MD.

Gender
Male 206
Female 233
Ethnicity
Black / African American 0
Asian / Pacific Islander 0
Non-Hispanic White 391
Hispanic 1
Native American / Alaskan Native 0
Other 2
Age
75 to 84 135
85 and over 37
Less than 65 47
65 to 74 218

Average of Total of Conditions of Medicare patients treated by Dr. Christopher Andrew Yasenchak, MD From 2013 - 2023

The highest averages of the most common conditions of Medicare patients that Dr. Christopher Andrew Yasenchak, MD treated were hypertension, high cholesterol, cancer and chronic kidney disease.

Hypertension 55
High Cholesterol 42
Stroke 3
Ischemic Heart Disease 24
Depression 19
Chronic Kidney Disease 33
Asthma 8
Osteoporosis 9
Heart Failure 17
Chronic Obstructive Pulmonary Disease 14
Diabetes 22
Atrial Fibrillation 11
Dementia 5
Cancer 36

Education & Training

Dr. Christopher Andrew Yasenchak, MD graduated from Penn State College of Medicine in 1999. He completed residency at Mayo Clinic. He is certified by the Board Certification: Hematology and has a state license in Oregon.

Medical School: Penn State College of Medicine (1999)

Residency: Mayo Clinic

Board Certification: Board Certification: Hematology

Licensed In: Oregon

Affiliations & Hospitals

Dr. Christopher Andrew Yasenchak, MD is associated with these hospitals and organizations:

Samaritan Health System
ONCOLOGY ASSOCIATES OF OREGON P C

Ratings & Reviews

Dr. Christopher Andrew Yasenchak, MD does not have any reviews yet, be the first to leave a review of Dr. Christopher Andrew Yasenchak, MD here: Leave a Review

(No ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Christopher Andrew Yasenchak, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

Payments by Company
BeiGene USA, Inc. $48,664 BRUKINSA
$46,064 		TEVIMBRA
$1,625
$975
Seattle Genetics, Inc. $18,167 ADCETRIS
$10,418 		SGN35
$7,432
$318
Lilly USA, LLC $10,939
$10,939
Takeda Pharmaceuticals U.S.A., Inc. $9,436
$9,436
Seagen Inc. $8,470 ADCETRIS
$4,020
$4,450
Other $13,772 ADCETRIS
$4,777 		Pomalyst
$1,500 		MONJUVI
$1,455 		TECVAYLI
$1,350 		IMBRUVICA
$212 		Other
$4,478
Types of Payments
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $72,868
Consulting Fee $19,673
Travel and Lodging $8,131
Honoraria $7,000
Food and Beverage $1,407
Other $370

Research Payments

Dr. Christopher Andrew Yasenchak, MD has received 1332 research payments totaling $4,289,998.

Biography

Dr. Christopher Yasenchak's specialties are general practice, adult hematology, and adult oncology. He practices in Eugene, OR, Corvallis, OR, and Florence, OR. He is professionally affiliated with Samaritan Health System. He studied medicine at Penn State College of Medicine. Dr. Yasenchak's residency was performed at Mayo Clinic.

Other Providers in Newport, OR